mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.053 |
0.7 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.7 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |